[1]
D. A. Glaser, “Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis”, J of Skin, vol. 1, no. 3.1, p. s95, Oct. 2017.